報價延遲最少15分鐘:2025/08/25 06:06 EDT
盤前時段
|
||||
|
-- 
|
|
|
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
44.83
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.43/0.77
|
|
企業價值
2.39B
|
| 資產負債 |
|
每股賬面淨值
8.90
|
| 現金流量 |
|
現金流量率
0.01
|
| 損益表 |
|
收益
388.54M
|
|
每股收益
7.20
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
報價延遲最少15分鐘：2025/08/25 06:06 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America. |
